203 related articles for article (PubMed ID: 12629418)
1. Morphology, phenotype and ultrastructure of fibroblastic cells from normal and neuropathic human detrusor: absence of myofibroblast characteristics.
Drake MJ; Hedlund P; Andersson KE; Brading AF; Hussain I; Fowler C; Landon DN
J Urol; 2003 Apr; 169(4):1573-6. PubMed ID: 12629418
[TBL] [Abstract][Full Text] [Related]
2. Alterations in connexin expression in the bladder of patients with urge symptoms.
Neuhaus J; Pfeiffer F; Wolburg H; Horn LC; Dorschner W
BJU Int; 2005 Sep; 96(4):670-6. PubMed ID: 16104929
[TBL] [Abstract][Full Text] [Related]
3. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations.
Mukerji G; Yiangou Y; Grogono J; Underwood J; Agarwal SK; Khullar V; Anand P
J Urol; 2006 Jul; 176(1):367-73. PubMed ID: 16753445
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of neurogenic bladder dysfunction. I. Methods of prospective ultrastructural study and overview of the findings.
Elbadawi A; Resnick NM; Dörsam J; Yalla SV; Haferkamp A
J Urol; 2003 Feb; 169(2):540-6. PubMed ID: 12544304
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblast-derived smooth muscle cells during remodelling of rabbit urinary bladder wall induced by partial outflow obstruction.
Buoro S; Ferrarese P; Chiavegato A; Roelofs M; Scatena M; Pauletto P; Passerini-Glazel G; Pagano F; Sartore S
Lab Invest; 1993 Nov; 69(5):589-602. PubMed ID: 8246451
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of neurogenic bladder dysfunction. II. Myogenic basis of detrusor hyperreflexia.
Haferkamp A; Dörsam J; Resnick NM; Yalla SV; Elbadawi A
J Urol; 2003 Feb; 169(2):547-54. PubMed ID: 12544305
[TBL] [Abstract][Full Text] [Related]
7. Cadherin-11 is expressed in detrusor smooth muscle cells and myofibroblasts of normal human bladder.
Kuijpers KA; Heesakkers JP; Jansen CF; Schalken JA
Eur Urol; 2007 Oct; 52(4):1213-21. PubMed ID: 17292535
[TBL] [Abstract][Full Text] [Related]
8. [Phenotypic changes in human bladder smooth muscle cell].
Matsumoto S; Hanai T; Kurita T; Akiyama T
Hinyokika Kiyo; 2003 Dec; 49(12):715-9. PubMed ID: 14978953
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of neurogenic bladder dysfunction. III. Intrinsic detrusor innervation.
Haferkamp A; Dörsam J; Resnick NM; Yalla SV; Elbadawi A
J Urol; 2003 Feb; 169(2):555-62. PubMed ID: 12544306
[TBL] [Abstract][Full Text] [Related]
10. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
[TBL] [Abstract][Full Text] [Related]
11. Assessing the effects of transforming growth factor-beta1 on bladder smooth muscle cell phenotype. I. Modulation of in vitro contractility.
Parekh A; Long RA; Iannone EC; Chancellor MB; Sacks MS
J Urol; 2009 Sep; 182(3):1210-5. PubMed ID: 19625042
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of bladder smooth muscle in fetal rats with retinoic acid-induced myelomeningocele.
Danzer E; Kiddoo DA; Redden RA; Robinson L; Radu A; Zderic SA; Doolin EJ; Adzick NS; Flake AW
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F197-206. PubMed ID: 16940565
[TBL] [Abstract][Full Text] [Related]
13. The functional effects of a c-kit tyrosine inhibitor on guinea-pig and human detrusor.
Biers SM; Reynard JM; Doore T; Brading AF
BJU Int; 2006 Mar; 97(3):612-6. PubMed ID: 16469036
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuropathic bladder smooth muscle cells in culture.
Lin HK; Cowan R; Moore P; Zhang Y; Yang Q; Peterson JA; Tomasek JJ; Kropp BP; Cheng E
J Urol; 2004 Mar; 171(3):1348-52. PubMed ID: 14767346
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on morphological changes of detrusor muscle and its neuromuscular junction after medullary cone injury in rats].
Hou C; Zheng X; Chen A
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):473-7. PubMed ID: 17578285
[TBL] [Abstract][Full Text] [Related]
16. A qualitative ultrastructural study of the hypocontractile detrusor.
Hindley RG; Brierly RD; McLarty E; Harding DM; Thomas PJ
J Urol; 2002 Jul; 168(1):126-31. PubMed ID: 12050505
[TBL] [Abstract][Full Text] [Related]
17. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
Howard PS; Renfrow D; Schechter NM; Kucich U
Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
[TBL] [Abstract][Full Text] [Related]
18. Over expression of smooth muscle specific caldesmon by transfection and intermittent agonist induced contraction alters cellular morphology and restores differentiated smooth muscle phenotype.
Shukla AR; Nguyen T; Zheng Y; Zderic SA; DiSanto M; Wein AJ; Chacko S
J Urol; 2004 May; 171(5):1949-54. PubMed ID: 15076319
[TBL] [Abstract][Full Text] [Related]
19. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M
Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448
[TBL] [Abstract][Full Text] [Related]
20. Detrusor morphology and pathology in relation to bladder outflow obstruction in bilharzial patients.
el-Feky H; Mangoud AM; Aly MA; Eissa MH; Abdel-Wahab RM; Kamhawy M; Ghobish A; Sabry AH; el Zayyat EA; Morsy TA
J Egypt Soc Parasitol; 1991 Dec; 21(3):699-706. PubMed ID: 1765681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
